Estepan Ian Michael — SEC Form 4 filings
SEC reporting owner CIK 1836254. 21 Form 4 filings on record with FilingPulse; latest filed 2026-09-08.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2024-03-05 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 20,372 shares, $1,270,262 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 46.
- Largest priced transaction: sale of 5,985 shares @ $137.36 ($822,100) in Sarepta Therapeutics, Inc., filed 2024-09-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | Chief Operating Officer | 21 | — | 3 legs · 20,372 sh · $1,270,262 | 46 |
Form 4 filings — Estepan Ian Michael
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-08 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 24,799 @ $22.22 | EDGAR |
| 2026-03-13 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 1,097 @ $17.03 | EDGAR |
| 2026-03-11 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 1,036 @ $16.95 · Tax withholding (F): 583 @ $16.95 | EDGAR |
| 2026-03-03 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Option exercise (M): 8,125 · Tax withholding (F): 3,301 @ $16.20 · Tax withholding (F): 875 @ $16.20 · Option exercise (M): 8,125 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Option exercise (M): 2,069 @ $13.71 · Option exercise (M): 5,381 @ $13.71 · Option exercise (M): 2,069 (derivative) @ $0 · Option exercise (M): 5,381 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 1,875 (derivative) | EDGAR |
| 2025-12-18 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Sale (S): 13,187 @ $22.31 | EDGAR |
| 2025-09-05 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 93,875 @ $0 · Grant/award (A): 50,000 @ $0 | EDGAR |
| 2025-08-06 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 6,250 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Option exercise (M): 5,500 · Tax withholding (F): 1,051 @ $100.13 · Tax withholding (F): 2,890 @ $100.13 · Grant/award (A): 8,276 · Option exercise (M): 5,500 (derivative) @ $0 · Grant/award (A): 16,644 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Option exercise (M): 17,500 · Tax withholding (F): 585 @ $103.70 · Tax withholding (F): 9,094 @ $103.70 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2025-03-06 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 1,370 @ $101.34 | EDGAR |
| 2025-03-04 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 557 @ $103.77 | EDGAR |
| 2025-02-13 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Grant/award (A): 3,500 (derivative) @ $0 | EDGAR |
| 2025-01-31 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Option exercise (M): 14,267 @ $12 · Option exercise (M): 1,533 @ $12 · Tax withholding (F): 2,613 @ $117.51 · Option exercise (M): 14,267 (derivative) @ $0 · Option exercise (M): 1,533 (derivative) @ $0 | EDGAR |
| 2024-12-30 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Gift (G): 250 @ $0 | EDGAR |
| 2024-09-03 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Sale (S): 5,985 @ $137.36 | EDGAR |
| 2024-06-25 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Option exercise (M): 6,250 · Tax withholding (F): 2,483 @ $164.64 · Grant/award (A): 5,500 (derivative) @ $0 · Grant/award (A): 6,250 (derivative) @ $0 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 526 @ $120.49 · Tax withholding (F): 1,035 @ $123.14 | EDGAR |
| 2024-03-06 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 1,389 @ $125.32 | EDGAR |
| 2024-03-05 | 4 | Sarepta Therapeutics, Inc. (SRPT) | Tax withholding (F): 365 @ $126.19 · Grant/award (A): 6,000 @ $0 · Sale (S): 1,200 @ $128.30 · Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1836254 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →